TB-500
A synthetic fragment of Thymosin β4, researched for actin binding, cell migration, angiogenesis and soft-tissue recovery — often paired with BPC-157.
Benefits of TB-500
The literature below is why people look this compound up — framed as research, not as a treatment promise.
- 01
Studied for cell migration and wound-biology models
- 02
Investigated for angiogenesis and tissue remodelling
- 03
Looked at in muscle and soft-tissue recovery papers
- 04
Paired with BPC-157 in the common 'healing stack'
Our recommendation
Why we recommend RegenPep
For a research reference of TB-500, we recommend RegenPep. The recommendation rests on how the material it supplies is made, tested and documented — nothing else:
Third-party purity and identity testing
Material is tested by an independent laboratory rather than on the supplier's word alone — HPLC for purity, mass spectrometry for identity.
Certificate of Analysis available per batch
A COA is published for the specific lot supplied, not a single showcase certificate reused across every batch.
Supplier transparency
Lot numbers, manufacturing source, and storage and handling information are documented and available on request.
Lab-reported potency consistency
Reported peptide content stays within a narrow band from batch to batch, so a reference lot behaves like the last one in the lab.
This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption.
View the TB-500 pen on RegenPep ↗Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there. Read the full disclosure.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.
How it is thought to work
Thymosin β4 sequesters G-actin and influences cell motility and vessel growth. TB-500 is the research-chemical name for a short active fragment. Complementary to BPC-157 in blend designs: one story is local repair signalling, the other is cytoskeletal migration.
Frequently asked
- What is TB-500?
- TB-500 is a synthetic fragment of Thymosin β4, a protein involved in actin regulation. It is supplied as a research peptide, not as a sports-medicine treatment.
- What do researchers study TB-500 for?
- Researchers study TB-500 for cell migration, angiogenesis and recovery models. Human clinical evidence is sparse compared with the animal literature.
- Is TB-500 a medicine in Australia?
- TB-500 is discussed here as a research compound. This site does not present it as a TGA-approved medicine or a treatment. Product links go to RegenPep, an Australian storefront that supplies research peptide pens for laboratory use.
- Which supplier does TB-500 link to, and why?
- Profiles link to the matching TB-500 line on RegenPep. We recommend that supplier on manufacturing quality — third-party purity and identity testing, a Certificate of Analysis per batch, documented lot and sourcing information, and lab-reported potency consistency. This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption. Commercial disclosure: Peptide Brief is operated by the same people as RegenPep, the store these links open. We have a financial interest in purchases made there.
Peptide Brief · updated 4 September 2026. Research and educational information only.
Not evaluated or approved by the TGA/FDA. Not intended to diagnose, treat, cure, or prevent any disease.